Privi Speciality Chemicals Ltd reported a reduction in institutional holding as SBI Mutual Fund disposed of 18,400 shares on September 24, 2026. The transaction lowered the mutual fund's aggregate stake across its various schemes to 7.3434% of the company's paid-up share capital.

Disclosure Details

The disposal was executed via market sale and disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Prior to this transaction, SBI Mutual Fund held 28,86,944 shares, representing 7.3905% of the equity. The sale reduced the absolute number of shares held by the fund by a marginal amount relative to its total position.

Shareholding Structure

The company's total equity share capital remained unchanged at ₹39,06,27,060, comprising 39,06,27,060 equity shares with a face value of ₹10 each. The disclosure confirms that the reduction pertains solely to shares carrying voting rights, with no encumbrances, warrants, or convertible securities involved in the transaction.

SBI Funds Management Limited, acting through its Chief Compliance Officer Vinaya Datar, submitted the filing to both BSE Limited and the National Stock Exchange of India Limited. The transaction date was recorded as September 24, 2026, with the formal intimation dated September 25, 2026.

Privi Speciality Chemicals Limited has announced that a meeting of its equity shareholders will be held on Tuesday, October 27, 2026, at 12:30 pm via Video Conferencing (VC) and Other Audio-Visual Means (OAVM). The primary agenda is to consider and approve the proposed Scheme of Amalgamation involving two private subsidiaries.

The National Company Law Tribunal (NCLT), Mumbai Bench, directed the convening of this meeting through an order dated September 7, 2026. The scheme involves the amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with the listed entity. These entities are referred to as Transferor Company 1 and Transferor Company 2, respectively, while the main company acts as the Transferee Company.

Meeting Logistics and Voting Details

The company dispatched the Notice of Meeting along with Annexures on September 24, 2026, to members whose email addresses were registered as of September 18, 2026. The notice and explanatory statement are also available on the company's official website. To facilitate participation, remote e-voting facilities will be provided alongside the virtual meeting.

Regulatory Framework

The proposed scheme is being executed under sections 230 to 232 and other applicable provisions of the Companies Act, 2013, along with the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016. The NCLT order was passed in the Company Scheme Application No. CA(CAA)136/MB/2026.

Members can access the live webcast and voting portal through the designated link provided by the Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The company has ensured that all procedural requirements for the electronic dispatch of notices are met to enable seamless participation for equity shareholders.